ES2198139T3 - Compuestos de dibenzotiofeno y procedimientos de uso de los mismos. - Google Patents

Compuestos de dibenzotiofeno y procedimientos de uso de los mismos.

Info

Publication number
ES2198139T3
ES2198139T3 ES99930662T ES99930662T ES2198139T3 ES 2198139 T3 ES2198139 T3 ES 2198139T3 ES 99930662 T ES99930662 T ES 99930662T ES 99930662 T ES99930662 T ES 99930662T ES 2198139 T3 ES2198139 T3 ES 2198139T3
Authority
ES
Spain
Prior art keywords
alkyl
compound
compounds
formula
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99930662T
Other languages
English (en)
Spanish (es)
Inventor
Richard R. Tidwell
James Edwin Hall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of North Carolina at Chapel Hill
Original Assignee
University of North Carolina at Chapel Hill
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of North Carolina at Chapel Hill filed Critical University of North Carolina at Chapel Hill
Application granted granted Critical
Publication of ES2198139T3 publication Critical patent/ES2198139T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/91—Dibenzofurans; Hydrogenated dibenzofurans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/08—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/76—Dibenzothiophenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
ES99930662T 1998-08-20 1999-06-24 Compuestos de dibenzotiofeno y procedimientos de uso de los mismos. Expired - Lifetime ES2198139T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9727398P 1998-08-20 1998-08-20
US97273P 1998-08-20

Publications (1)

Publication Number Publication Date
ES2198139T3 true ES2198139T3 (es) 2004-01-16

Family

ID=22262567

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99930662T Expired - Lifetime ES2198139T3 (es) 1998-08-20 1999-06-24 Compuestos de dibenzotiofeno y procedimientos de uso de los mismos.

Country Status (9)

Country Link
US (1) US6172104B1 (enExample)
EP (1) EP1105381B1 (enExample)
JP (1) JP2003523927A (enExample)
AT (1) ATE239003T1 (enExample)
AU (1) AU758563B2 (enExample)
CA (1) CA2340912C (enExample)
DE (1) DE69907476T2 (enExample)
ES (1) ES2198139T3 (enExample)
WO (1) WO2000010990A2 (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2784678B1 (fr) * 1998-09-23 2002-11-29 Sod Conseils Rech Applic Nouveaux derives de n-(iminomethyl)amines, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
US6569853B1 (en) * 2000-11-06 2003-05-27 Combinatorx, Incorporated Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders
GB2380192B8 (en) * 2001-02-09 2005-09-14 Sumitomo Chemical Co Phenylacetylene compounds liquid crystal compositions polymers optically anisotropic products & optical & liquid crystal elements derived therefrom
JP2002255960A (ja) * 2001-02-27 2002-09-11 Sumitomo Chem Co Ltd ジベンゾチオフェン化合物、中間体およびその製造方法
JP2005505508A (ja) * 2001-06-13 2005-02-24 ジーンソフト ファーマシューティカルズ インコーポレイテッド 抗感染活性を有するベンゾチオフェン化合物
BR0212078A (pt) * 2001-08-31 2004-09-28 Neurochem Int Ltd Método de tratar ou prevenir uma doença relacionada com amilóide em um paciente, composição farmacêutica, composto quìmico, e, uso de um composto
SG124249A1 (en) * 2001-12-07 2006-08-30 Sumitomo Chemical Co New polymer and polymer light-emitting device using the same
JP4957669B2 (ja) * 2002-03-15 2012-06-20 住友化学株式会社 高分子化合物およびそれを用いた高分子発光素子
AU2003258022A1 (en) 2002-08-02 2004-02-23 Genesoft Pharmaceuticals, Inc. Biaryl compounds having anti-infective activity
US7265129B2 (en) * 2002-10-25 2007-09-04 Genesoft Pharmaceuticals, Inc. Anti-infective biaryl compounds
EP1587529A4 (en) 2002-12-10 2009-08-12 Oscient Pharmaceuticals Corp ANTIBACTERIAL COMPOUNDS WITH (PYROCARBOXAMIDE) - (BENZAMID) - (IMIDAZOLE CARBOXAMIDE) MOTIVE
US20050054708A1 (en) * 2003-07-28 2005-03-10 Nichols Matthew James Combinations of drugs for the treatment of neoplasms
US20050080075A1 (en) * 2003-08-25 2005-04-14 Nichols M. James Formulations, conjugates, and combinations of drugs for the treatment of neoplasms
US20050158320A1 (en) * 2003-11-12 2005-07-21 Nichols M. J. Combinations for the treatment of proliferative diseases
US20050100508A1 (en) * 2003-11-12 2005-05-12 Nichols M. J. Methods for identifying drug combinations for the treatment of proliferative diseases
WO2005051296A2 (en) * 2003-11-24 2005-06-09 University Of North Carolina At Chapel Hill Fused ring dicationic anti-protozoan agents and their prodrugs
US7262223B2 (en) * 2004-01-23 2007-08-28 Neurochem (International) Limited Amidine derivatives for treating amyloidosis
US7365193B2 (en) 2004-02-04 2008-04-29 Abbott Laboratories Amino-substituted tricyclic derivatives and methods of use
US7994225B2 (en) * 2004-03-17 2011-08-09 Rempex Pharmaceuticals, Inc. Bacterial efflux pump inhibitors for the treatment of ophthalmic and otic infections
CA2559208A1 (en) * 2004-03-17 2005-09-29 Mpex Pharmaceuticals, Inc. Use and administration of bacterial efflux pump inhibitors
DE102004031656A1 (de) * 2004-06-30 2006-01-19 Merck Patent Gmbh Tetrahydrochinoline
GB0619325D0 (en) * 2006-09-30 2006-11-08 Univ Strathclyde New compounds
US20090092574A1 (en) 2006-12-29 2009-04-09 Scott Richard W Ophthalmic And Otic Compositions Of Facially Amphiphilic Polymers And Oligomers And Uses Thereof
DE102007013854A1 (de) 2007-03-20 2008-09-25 Merck Patent Gmbh Tetrahydrochinoline
DE102007013855A1 (de) 2007-03-20 2008-09-25 Merck Patent Gmbh Substituierte Tetrahydrochinoline
DE102007013856A1 (de) 2007-03-20 2008-09-25 Merck Patent Gmbh Substituierte Tetrahydropyrrolochinoline
CA2732572A1 (en) * 2008-07-28 2010-02-04 Polymedix, Inc. Anti-malarial compounds
US8278309B2 (en) 2008-10-27 2012-10-02 Polymedix, Inc. Synthetic mimetics of host defense and uses thereof
BR112012016570A2 (pt) * 2010-01-07 2016-04-05 Polymedix Inc composto, composição farmacêutica, método para antagonizar a heparina não fracionada, heparina de peso molecular baixo, ou derivado de heparina /heparina de peso molecular baixo, e, uso do composto
TWI520951B (zh) 2011-05-16 2016-02-11 塞爾西優蒂克斯公司 用於治療粘膜炎的化合物
US11771694B2 (en) 2020-06-05 2023-10-03 Innovation Pharmaceuticals Inc. Arylamide compounds for treatment and prevention of viral infections

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2500734A (en) * 1946-06-13 1950-03-14 Gen Electric Process of preparing 2-ethyldibenzofuran
GB932813A (en) * 1960-12-01 1963-07-31 Monsanto Chemicals New heterocyclic chemical compounds
GB951797A (en) * 1960-12-20 1964-03-11 Monsanto Chemicals Heterocyclic compounds
US4362883A (en) * 1981-10-28 1982-12-07 The Halcon Sd Group, Inc. Preparation of dibenzofuran
AU626033B2 (en) 1988-10-25 1992-07-23 Government Of The United States Of America, As Represented By The Secretary Of The Army, The Methods for the treatment and prophylaxis of pneumocystis carinii pneumonia and other diseases and compounds and formulations for use in said methods
IL115875A (en) 1994-11-14 2000-12-06 Univ Georgia State Res Found Methods of inhibiting pneumocystis carinii pneumonia giardia lamblia and cryptosporidium parvum in an animal subject and compounds useful therefor
US5668166A (en) * 1995-06-07 1997-09-16 Georgia State University Research Foundation, Inc. Methods of inhibiting pneumocystis carinii pneumonia and compounds useful therefor
WO1996040117A1 (en) 1995-06-07 1996-12-19 The University Of North Carolina At Chapel Hill Methods of treating microbial infections
US5723495A (en) * 1995-11-16 1998-03-03 The University Of North Carolina At Chapel Hill Benzamidoxime prodrugs as antipneumocystic agents

Also Published As

Publication number Publication date
DE69907476D1 (de) 2003-06-05
AU758563B2 (en) 2003-03-27
EP1105381B1 (en) 2003-05-02
AU4715299A (en) 2000-03-14
WO2000010990A3 (en) 2003-04-17
US6172104B1 (en) 2001-01-09
WO2000010990A2 (en) 2000-03-02
ATE239003T1 (de) 2003-05-15
CA2340912C (en) 2008-11-18
JP2003523927A (ja) 2003-08-12
CA2340912A1 (en) 2000-03-02
DE69907476T2 (de) 2004-04-15
EP1105381A1 (en) 2001-06-13

Similar Documents

Publication Publication Date Title
ES2198139T3 (es) Compuestos de dibenzotiofeno y procedimientos de uso de los mismos.
ES2871027T3 (es) Inhibidores potentes de la epóxido hidrolasa soluble
JP5932008B2 (ja) Ｎａｄｐｈオキシダーゼインヒビターとしてのピラゾロピリジン誘導体を含む医薬製剤
ES2437346T3 (es) Procedimiento para la producción de derivado de diamina
KR20060127909A (ko) 호흡기 다핵체 바이러스 감염 치료용 다환 물질
JP2005519907A (ja) Ｈｉｖインテグラーゼ阻害薬として有用なヒドロキシナフチリジノンカルボキサミド類
WO2011135303A2 (en) Ubiquitination modulators
CN113768870B (zh) 含青蒿琥酯的组合物及其应用
ES2236734T3 (es) Metodos para combatir la neumonia pneumocystis carinii y compuestos utiles para ello.
WO2013134371A1 (en) Methods and compounds to be used in the treatment of neurodegenerative diseases
ES2554360T3 (es) Bencenosulfonato de 2-[[[2-[(hidroxiacetil)amino]-4-piridinil]metil]tio]-n-[4 (trifluorometoxi)fenil]-3-piridincarboxamida, cristales del mismo, polimorfos del mismo y procesos para la producción del mismo
JP2000256343A (ja) 抗ニューモシスティスカリニ剤としての２，４−ビス〔（４−アミジノ）フェニル〕フラン類
EP3424925A1 (en) Novel hdac6 inhibitors, with improved solubility and their uses
ES2316001T3 (es) Derivados de 5,5-bis-(4-amidinofenil)-2,2' bifurano y compuestos relacionados como agentes antiprotozoos, y prodrogas de los mismos.
US7799799B2 (en) Indolizine derivatives, method for preparing same, and therapeutic compositions comprising same
EP0792271B1 (en) Furan derivatives for inhibiting pneumocystis carinii pneumonia, giardia lamblia and cryptosporidium parvum
JP2010501641A (ja) Ｈｓｐ９０阻害剤として有用な１ｈ−ピロロ［２，３−ｂ］ピリジン誘導体
ES2463190B1 (es) Formas cristalinas de sartanes tales como telmisartán con betabloqueantes
ES2211958T3 (es) Carbazoles para tratar infecciones microbianas.
ES2219395T3 (es) Sal anhidra.
CN118440052B (zh) 一种化合物及其在制备tyk2激酶抑制剂中的用途
CN1444585A (zh) 晶体治疗剂
WO2023226614A1 (zh) N-(吡啶-2-基)吡啶-2-硫代酰胺或其盐在制备抗缺氧药物中的用途
WO2024175053A1 (zh) 治疗或预防败血症或与败血症相关的病情的化合物
US20240317717A1 (en) Sulfonamide compounds and the use thereof in the treatment of cancer